finerenone
bayer
[]
an analysis of the fidelity program from #esccongress details an 11% reduction in risk of all-cause mortality and a 25% reduction in risk of sudden cardiac death among patients with type 2 diabetes and chronic kidney disease. #diabetes #type2diabetes
https://t.co/oO8rFDu0YA is an online medical news website dedicated to providing clinically impactful news related to endocrinology.